Keith Vendola

Director of Finance/CFO at NERVGEN PHARMA CORP.

Net worth: - $ as of 31/07/2026

54 year

38 connections

Health Technology

Consumer Services

Technology Services

Profile

Keith A. Vendola is currently Chief Financial Officer at NervGen Pharma Corp.
Former positions include Senior Director-Business Development at Threshold Pharmaceuticals, Inc., Chief Financial Officer at Wugen, Inc., Head-Corporate Development at DiObex, Inc., Vice President-Finance & Corporate Development at Eiger BioPharmaceuticals, Inc., Chief of Staff & VP-Competitive Strategy at Coherus Oncology, Inc. from 2015 to 2017, Chief Strategy Officer at Rezolute, Inc. from 2020 to 2021, and Chief Financial Officer at IO Biotech, Inc. from 2021 to 2022.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from Dartmouth Medical School, and an MBA from Kellogg School of Management.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NERVGEN PHARMA CORP. -.--%	27/04/2026	0 ( -.--% )	- $	31/07/2026

Keith Vendola active positions

Companies	Position	Start
NERVGEN PHARMA CORP.	Director of Finance/CFO	27/04/2026

All active positions of Keith Vendola

Former positions of Keith Vendola

Companies	Position	End
IO BIOTECH, INC.	Director of Finance/CFO	09/05/2022
REZOLUTE, INC.	Director of Finance/CFO	06/11/2020
COHERUS ONCOLOGY, INC.	Human Resources Officer	01/06/2017
Wugen, Inc. Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies	Director of Finance/CFO	-
Eiger BioPharmaceuticals, Inc. /Old/ Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products	Director of Finance/CFO	-

See the detail of Keith Vendola's experience

Training of Keith Vendola

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Vendola's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Threshold Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
DiObex, Inc. DiObex, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic disease treatment	Health Technology
Eiger BioPharmaceuticals, Inc. /Old/ Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products	Health Technology
College of the Holy Cross (Massachusetts) College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Dartmouth Medical School Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Coherus BioSciences, Inc. Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer	Health Technology
Rezolute, Inc. Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance	Health Technology
Kellogg School of Management Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NervGen Pharma Corp. NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders	Health Technology
Wugen, Inc. Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies	Technology Services
IO Biotech, Inc. IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies	Health Technology